Technical Analysis for GSK - GlaxoSmithKline PLC

Grade Last Price % Change Price Change
grade D 39.06 0.21% 0.08
GSK closed up 0.21 percent on Friday, January 18, 2019, on 1.55 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.

Earnings due: Feb 6

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Flat
See historical GSK trend table...

Date Alert Name Type % Chg
Jan 18 50 DMA Resistance Bearish 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Doji - Bearish? Reversal 0.00%
Jan 16 Narrow Range Bar Range Contraction 1.69%
Jan 16 Doji - Bullish? Reversal 1.69%
Jan 15 Overbought Stochastic Strength 0.03%
Jan 14 Fell Below 50 DMA Bearish 1.17%
Jan 14 Stochastic Sell Signal Bearish 1.17%

Older signals for GSK ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
GlaxoSmithKline plc, together with its subsidiaries, discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also produces paediatric and adult vaccines to prevent a range of infectious diseases, including hepatitis A and B; diphtheria, tetanus, and whooping cough; measles, mumps, and rubella; polio; typhoid; influenza; and bacterial meningitis. In addition, it provides consumer health products in oral care, nutritional, total wellness, and skin health areas. The company's total wellness products include Panadol for the treatment of paracetamol-based treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; ENO Tums, a rapid relief antacid; and oral care products comprise Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to improve comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. Its nutrition products include Lucozade for energy and hydration; and Horlicks and Maxinutrition for nutrition; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Is GSK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 42.36
52 Week Low 34.2991
Average Volume 3,803,809
200-Day Moving Average 40.0375
50-Day Moving Average 39.12
20-Day Moving Average 38.4665
10-Day Moving Average 38.992
Average True Range 0.6849
ADX 11.64
+DI 27.5997
-DI 20.8789
Chandelier Exit (Long, 3 ATRs ) 37.5153
Chandelier Exit (Short, 3 ATRs ) 38.9247
Upper Bollinger Band 39.6999
Lower Bollinger Band 37.2331
Percent B (%b) 0.74
BandWidth 6.412853
MACD Line 0.0991
MACD Signal Line -0.005
MACD Histogram 0.1041
Fundamentals Value
Market Cap 95.47 Billion
Num Shares 2.44 Billion
EPS 1.03
Price-to-Earnings (P/E) Ratio 37.92
Price-to-Sales 2.27
Price-to-Book 83.56
PEG Ratio 1.10
Dividend 1.99
Dividend Yield 5.09%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 39.52
Resistance 3 (R3) 39.52 39.37 39.44
Resistance 2 (R2) 39.37 39.25 39.37 39.42
Resistance 1 (R1) 39.22 39.18 39.29 39.21 39.39
Pivot Point 39.07 39.07 39.10 39.06 39.07
Support 1 (S1) 38.91 38.95 38.99 38.91 38.73
Support 2 (S2) 38.76 38.88 38.76 38.70
Support 3 (S3) 38.61 38.76 38.68
Support 4 (S4) 38.60